Payment overview · 2025
General Payments
$245.95
12 reported records · 5 companies
Healthcare provider profile · identity verified
Leanne M Camisa, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · PLACERVILLE, CA · NPI 1124081377
Verified facts
What the public records show
CMS Open Payments records show Leanne M Camisa, M.D. received $245.95 in general payments during 2025 across 12 reported records.
Amgen Inc. accounted for 43.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $107.29 | 43.6% | 5 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $55.47 | 22.6% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $48.61 | 19.8% | 2 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $18.47 | 7.5% | 1 | 2025 |
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $16.11 | 6.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $245.95 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $107.29 | 5 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $55.47 | 3 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $24.50 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $24.11 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $18.47 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $18.47 | 1 | 2025 |
Source payment records
|
|||||
| EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) Normalized: edwards sapien 3 transcatheter heart valve thv |
Device | Edwards Lifesciences Corporation | $16.11 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 657 | 221 |
| Levothyroxine Sodium | Levothyroxine Sodium | 430 | 141 |
| Lisinopril | Lisinopril | 327 | 110 |
| Losartan Potassium | Losartan Potassium | 309 | 97 |
| Omeprazole | Omeprazole | 297 | 93 |
| Amlodipine Besylate | Amlodipine Besylate | 261 | 93 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 222 | 76 |
| Gabapentin | Gabapentin | 219 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 177 | 60 |
| Tamsulosin Hcl | Tamsulosin Hcl | 165 | 56 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 153 | 70 |
| Metformin Hcl | Metformin Hcl | 144 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 138 | 50 |
| Trazodone Hcl | Trazodone Hcl | 133 | 49 |
| Sertraline Hcl | Sertraline Hcl | 128 | 45 |
| Potassium Chloride | Potassium Chloride | 124 | 42 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 115 | 36 |
| Atenolol | Atenolol | 114 | 34 |
| Simvastatin | Simvastatin | 114 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 112 | 45 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 40 |
| Furosemide | Furosemide | 101 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 93 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 92 | 39 |
| Ozempic | Semaglutide | 92 | 23 |
| Spironolactone | Spironolactone | 90 | 26 |
| Celecoxib | Celecoxib | 88 | 30 |
| Valsartan | Valsartan | 87 | 29 |
| Eliquis | Apixaban | 84 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 79 | 29 |
| Alprazolam | Alprazolam | 74 | 27 |
| Synthroid | Levothyroxine Sodium | 73 | 22 |
| Famotidine | Famotidine | 70 | 29 |
| Metformin Hcl Er | Metformin Hcl | 68 | 26 |
| Jardiance | Empagliflozin | 63 | 16 |
| Estradiol | Estradiol | 61 | 28 |
| Montelukast Sodium | Montelukast Sodium | 60 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 60 | 25 |
| Bupropion Xl | Bupropion Hcl | 59 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 24 |
| Alendronate Sodium | Alendronate Sodium | 56 | 18 |
| Allopurinol | Allopurinol | 54 | 20 |
| Tramadol Hcl | Tramadol Hcl | 51 | 16 |
| Donepezil Hcl | Donepezil Hcl | 49 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 49 | 14 |
| Lovastatin | Lovastatin | 48 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 48 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 47 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 46 | 13 |
| Prednisone | Prednisone | 46 | 29 |
| Carvedilol | Carvedilol | 45 | 13 |
| Finasteride | Finasteride | 45 | 15 |
| Januvia | Sitagliptin Phosphate | 45 | 14 |
| Baclofen | Baclofen | 44 | 12 |
| Ezetimibe | Ezetimibe | 44 | 15 |
| Meloxicam | Meloxicam | 43 | 22 |
| Valacyclovir | Valacyclovir Hcl | 41 | 17 |
| Lorazepam | Lorazepam | 38 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 37 | 29 |
| Ibuprofen | Ibuprofen | 36 | 21 |
| Glipizide Er | Glipizide | 35 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 35 | 13 |
| Buspirone Hcl | Buspirone Hcl | 34 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 34 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | 15 |
| Trulicity | Dulaglutide | 34 | 11 |
| Azelastine Hcl | Azelastine Hcl | 32 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 29 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | 12 |
| Memantine Hcl | Memantine Hcl | 29 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 27 | 18 |
| Mirtazapine | Mirtazapine | 27 | 13 |
| Benazepril Hcl | Benazepril Hcl | 26 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 26 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 26 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 25 | 22 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Acyclovir | Acyclovir | 23 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | 11 |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 23 |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Glimepiride | Glimepiride | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Buprenorphine | Buprenorphine | 20 | suppressed |
| Cephalexin | Cephalexin | 20 | 13 |
| Testosterone Cypionate | Testosterone Cypionate | 20 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 19 | 11 |
| Xarelto | Rivaroxaban | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Colchicine | Colchicine | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Progesterone | Progesterone, Micronized | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Armour Thyroid | Thyroid,pork | 15 | suppressed |
| Cholestyramine Light | Cholestyramine | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Eplerenone | Eplerenone | 15 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 15 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Glipizide | Glipizide | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Belsomra | Suvorexant | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Misoprostol | Misoprostol | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | 11 |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Testosterone | Testosterone | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
| Trospium Chloride | Trospium Chloride | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $245.95 · 12 records | Amgen Inc. | AREXVY, Cologuard Collection Kit, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), EVENITY, FREESTYLE LIBRE 3, SHINGRIX, The Cologuard Plus Collection Kit | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error